Board of Directors

The Board of Directors of Bellevue Group AG consists of the following persons as per December 31, 2025:

¹⁾ Further information on the committees is given below under «Internal organization».
²⁾ Chair Audit & Risk Committee.
³⁾ Chair Compensation Committee.

Veit de Maddalena assumed operational management of Bellevue Group as Executive Chairman of the Board of Directors as of 2 June 2025. At the same time, Prof. Dr. Urs Schenker was appointed Lead Independent Director, whose duties and authorities are defined in accordance with Art. 18 para. 2 of the Swiss Code of Best Practice for Corporate Governance. With the exception of the Chairman of the Board of Directors (since 2 June 2025), no member of the Board of Directors of Bellevue Group AG held operational management responsibilities for the Company or any of its subsidiaries in 2025 or during the three preceding financial years, nor did any member maintain significant business relationships with the Company or any of its subsidiaries.

EXECUTIVE CHAIRMAN OF THE BOARD

Veit de Maddalena (born 1967)

Veit de Maddalena is lic. rer. pol. (Economics) from the University of Berne and holds an MSc/Master in Finance from the London Business School. He has many years of leadership experience in the financial industry and is now exclusively active as an independent director on the boards of several family-owned companies. He was elected to the Board of Directors of Bellevue Group in 2018 and has served as its chairman since 2019. Since June 2025, he has held the position of Executive Chairman of the Board of Directors of Bellevue Group. Earlier in his career Veit de Maddalena was a Global Partner and Executive Board member with Rothschild & Co Group, where he was responsible for its global private banking business. He concurrently acted as CEO of Rothschild & Co Bank AG, Switzerland. He began his professional career at Credit Suisse.

MEMBER OF THE BOARD

Prof. Dr. Urs Schenker (born 1957)

Urs Schenker holds a doctorate in law from the University of Zurich (Dr. iur.) and Harvard (LLM). He is a titular professor at the University of St. Gallen and an attorney at Walder Wyss in Zurich, where he specializes in corporate, finance and capital markets law. Prior to that he worked for approx. 20 years as a lawyer (14 years as a partner) for Baker & McKenzie in Zurich. Urs Schenker has been a member of the Board of Directors since 2019 and has served as Lead Independent Director of Bellevue Group since June 2025.

MEMBER OF THE BOARD

Katrin Wehr-Seiter (born 1970)

Katrin Wehr-Seiter holds a degree in engineering from the Technical University of Chemnitz/DE as well as an MBA from INSEAD Business School, Fontainebleau/FR. Katrin Wehr-Seiter is Partner and CEO of BIP Capital Partners, Luxembourg. Previously, she was a Principal at the international private equity firm Permira and worked as an independent advisor for medium-sized companies and as a Senior Advisor for the financial investor Bridgepoint. She started her professional career at Siemens AG. Since 2019, she has been a member of the Board of Directors of Bellevue Group.

MEMBER OF THE BOARD

Barbara Angehrn Pavik (born 1974)

Barbara Angehrn Pavik holds a Bachelor’s and a Master’s degree in Business Administration from the University of St. Gallen. She has more than 20 years of leadership experience in the international biopharmaceutical industry in Europe and the United States. She is currently Chief Executive Officer of Numab Therapeutics AG. Previously, she served as Chief Executive Officer of Asceneuron, a clinical-stage biotechnology company focused on neurodegenerative diseases, where she was responsible for the strategic expansion and advancement of the pipeline. Prior to that, she was Chief Business Officer and a member of the Executive Committee of the Vifor Pharma Group, with responsibility for global commercial and corporate functions. She has also held senior positions at Amgen, Onyx Pharmaceuticals and Exelixis, and was co-founder of Stepstone Pharma, focusing on in-licensing activities outside the United States. Barbara Angehrn Pavik has been a member of the Board of Directors of Bellevue Group since 2023.

The other mandates of the members of the Board of Directors are shown in the remuneration report.

Election procedures

All members of the Board are elected individually by the general meeting of shareholders. The Board of Directors constitutes itself. The members of the Board of Directors are elected to a term of one year and may be reelected. There is no restriction in the number of reelections.

Statutory rules in relation to the number of permissible activities of the Board of Directors pursuant to Art. 62 (2)(1) CO 

Pursuant to Article 30 of the Articles of Association, the members of the Board of Directors may each execute a maximum of 20 activities, of which a maximum of five in listed companies. Excluded from this are activities in legal entities controlled by the company or which control the company. Also excluded from the restrictions are activities in foundations, charitable institutions and employee pension funds; however, these are restricted to a maximum of ten such activities.

According to Art. 30 of the Articles of Association, the term «activity» within the meaning of this provision refers to membership in the highest management and administrative bodies of other companies with a commercial purpose. Several activities in legal entities which are under unitary control or under the control of the same beneficial owner are considered to be one activity.